Type III Dysbetalipoproteinemia

NCT00214604 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipoproteinemia Type III

Interventions

DRUG: Rosuvastatin
DRUG: rosuvastatin
DRUG: pravastatin

Sponsor

AstraZeneca